Effects of IL-6/IL-6R axis alterations in serum, plasma and cerebrospinal fluid with the schizophrenia : an updated review and meta-analysis of 58 studies

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..

Studies investigating the association between IL-6/IL-6R axis and schizophrenia (SZ) susceptibility found inconsistent data. To reconcile the results, a systematic review followed by a meta-analysis was performed to assess the associations. This study followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A comprehensive search of the literature was carried out in July 2022 using electronic databases PubMed, EBSCO, Science Direct, PsychInfo, and Scopus. Study quality was assessed by the Newcastle-Ottawa scale. Pooled standard mean difference (SMD) with 95% confidence interval (CI) was calculated by fixed-effect or random-effect model analysis. Fifty-eight studies were identified, including 4,200 SZ patients and 4,531 controls. Our meta-analysis results showed an increase of IL-6 levels in plasma, serum, or CSF and decreased IL-6R levels in serum in patients under treatment. Further studies are needed to better elucidate the correlation between the IL-6/IL-6R axis and the schizophrenia.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:479

Enthalten in:

Molecular and cellular biochemistry - 479(2024), 3 vom: 08. März, Seite 525-537

Sprache:

Englisch

Beteiligte Personen:

González-Castro, Thelma Beatriz [VerfasserIn]
Tovilla-Zárate, Carlos Alfonso [VerfasserIn]
Juárez-Rojop, Isela Esther [VerfasserIn]
Hernández-Díaz, Yazmín [VerfasserIn]
López-Narváez, María Lilia [VerfasserIn]
Ortiz-Ojeda, Rosa Felicita [VerfasserIn]

Links:

Volltext

Themen:

Association
Cytokine
IL6R protein, human
Interleukin
Interleukin-6
Journal Article
Meta-Analysis
Receptor
Receptors, Interleukin-6
Schizophrenia
Systematic Review

Anmerkungen:

Date Completed 25.03.2024

Date Revised 04.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s11010-023-04747-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM356072630